Merck & Co (NYSE:MRK)., the second-largest U.S. drugmaker by revenue, is facing a jury trial over accusations that it ...

RFK Jr. said he would give up the fees after senators questioned him about the lawsuits in a pair of hearings.

Robert F. Kennedy Jr., who awaits confirmation as Donald Trump's Health and Human Services secretary, helped organize mass ...

Robert F. Kennedy Jr., Trump's pick to head the Department of Health and Human Services, faces scrutiny for fees he may earn from lawsuits against Merck.

Senators had objected to the financial conflict posed by Robert F. Kennedy Jr.’s decision to retain a financial stake in ...

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...

President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...

GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males Merck (NYSE: MRK), known as MSD outside of the United States and Canada ...

Lastly, it saw an improvement in gross margins, thanks to lower royalty rates for Keytruda and Gardasil. 2024 was also the year where Merck looked at inorganic growth to expand its pharmaceuticals ...

Merck (MRK) announced that the National Medical Products Administration of China approved Gardasil Vaccine for use in males 9-26 years of age to help prevent certain HPV-related cancers and diseases.

"The approval of GARDASIL for use in males 9-26 years old in China is a significant step forward in advancing public health," said Joseph Romanelli, president, Human Health International ...